Trial Profile
Phase II study of Paclitaxel and Nedaplatin for previously untreated patients with advanced squamous cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Nedaplatin (Primary) ; Paclitaxel (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 11 Sep 2012 New trial record